2005 immunosuppressive strategies in kidney transplantation: which role for the calcineurin inhibitors?
The calcineurin inhibitors (CNIs) cyclosporine and tacrolimus have been the cornerstones of immunosuppressive strategies in clinical transplantation. Currently, regimens that are most widely used for induction and maintenance therapy include CNIs. However, many clinical trials aiming at reducing or eliminating CNIs have been performed in recent years. Here, we review and discuss current and future immunosuppressive strategies with a special emphasis on the role of CNIs, in the light of recent studies in the field of kidney transplantation. In the current era, CNIs still play an important role.
Wong
Waichi
W
Renal and Transplantation Units, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Venetz
Jean-Pierre
JP
Tolkoff-Rubin
Nina
N
Pascual
Manuel
M
D065095:Calcineurin Inhibitors; D002986:Clinical Trials as Topic; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000009:adverse effects / Q000379:methods*; D016559:Tacrolimus / Q000494:pharmacology
D065095:Calcineurin Inhibitors; D007166:Immunosuppressive Agents; D016559:Tacrolimus